Moreover, multiple studies described the connection between NLRC5 and metabolic conditions including obesity, but also an interaction of NLRC5 with PPARγ1, a key regulator of lipid metabolism and beyond (106), fostering the transcriptional activity of the latter (14, 107–110). The gene discussed is PPARG; the disease is obesity disorder.